CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review

NDA FilingAzetukalnerNegative
AI Analysis

Summary

Xenon filed an NDA for azetukalner while pausing psychiatry trials to conduct a tolerability review.

Clinical Trial Data

Importance:6/10
Sentiment:
-0.30
NDA_filingpsychiatrytrial_pausetolerability_review
Related Companies

Read the original article

Published by yahoo_finance on September 27, 2026 4:02 PM

Read Original